Anne Samuel
Stock Analyst at JP Morgan
(3.93)
# 687
Out of 4,412 analysts
31
Total ratings
53.85%
Success rate
10.93%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Upgrades: Neutral | $25 | $23.82 | +4.95% | 3 | Apr 25, 2024 | |
| HQY HealthEquity | Maintains: Overweight | $86 → $108 | $80.26 | +34.56% | 4 | Apr 2, 2024 | |
| EVH Evolent Health | Maintains: Overweight | $53 → $52 | $27.65 | +88.07% | 3 | Mar 15, 2024 | |
| VEEV Veeva Systems | Maintains: Neutral | $183 → $222 | $200.91 | +10.50% | 3 | Mar 13, 2024 | |
| RCM R1 RCM | Downgrades: Neutral | $20 → $11 | $11.90 | -7.56% | 3 | Dec 13, 2023 | |
| MODN Model N | Downgrades: Neutral | $30 → $25 | $29.64 | -15.65% | 1 | Dec 13, 2023 | |
| HCAT Health Catalyst | Upgrades: Overweight | $14 → $11 | $6.03 | +82.42% | 2 | Dec 13, 2023 | |
| PINC Premier | Maintains: Neutral | $26 → $21 | $20.96 | +0.19% | 2 | Nov 13, 2023 | |
| IQV IQVIA Holdings | Maintains: Overweight | $262 → $239 | $234.88 | +1.75% | 2 | Nov 13, 2023 | |
| PGNY Progyny | Maintains: Overweight | $58 → $57 | $32.04 | +77.90% | 3 | Oct 9, 2023 | |
| CCSI Consensus Cloud Solutions | Maintains: Neutral | $51 → $41 | $12.27 | +234.15% | 2 | May 15, 2023 | |
| OMCL Omnicell | Maintains: Neutral | $140 → $57 | $27.86 | +104.59% | 2 | Nov 18, 2022 | |
| MDRX Veradigm | Maintains: Underweight | $19 → $20 | $7.96 | +151.26% | 1 | Nov 18, 2022 |
Doximity
Apr 25, 2024
Upgrades: Neutral
Price Target: $25
Current: $23.82
Upside: +4.95%
HealthEquity
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $80.26
Upside: +34.56%
Evolent Health
Mar 15, 2024
Maintains: Overweight
Price Target: $53 → $52
Current: $27.65
Upside: +88.07%
Veeva Systems
Mar 13, 2024
Maintains: Neutral
Price Target: $183 → $222
Current: $200.91
Upside: +10.50%
R1 RCM
Dec 13, 2023
Downgrades: Neutral
Price Target: $20 → $11
Current: $11.90
Upside: -7.56%
Model N
Dec 13, 2023
Downgrades: Neutral
Price Target: $30 → $25
Current: $29.64
Upside: -15.65%
Health Catalyst
Dec 13, 2023
Upgrades: Overweight
Price Target: $14 → $11
Current: $6.03
Upside: +82.42%
Premier
Nov 13, 2023
Maintains: Neutral
Price Target: $26 → $21
Current: $20.96
Upside: +0.19%
IQVIA Holdings
Nov 13, 2023
Maintains: Overweight
Price Target: $262 → $239
Current: $234.88
Upside: +1.75%
Progyny
Oct 9, 2023
Maintains: Overweight
Price Target: $58 → $57
Current: $32.04
Upside: +77.90%
Consensus Cloud Solutions
May 15, 2023
Maintains: Neutral
Price Target: $51 → $41
Current: $12.27
Upside: +234.15%
Omnicell
Nov 18, 2022
Maintains: Neutral
Price Target: $140 → $57
Current: $27.86
Upside: +104.59%
Veradigm
Nov 18, 2022
Maintains: Underweight
Price Target: $19 → $20
Current: $7.96
Upside: +151.26%